NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing comprehensive information and high-quality compounds for scientific advancement, particularly in the realm of cancer research.

1'-Acetoxychavicol Acetate, identified by CAS number 52946-22-2, is a fascinating organic compound with significant potential as a pharmaceutical intermediate. Its chemical structure and properties make it a subject of intense study for its therapeutic applications, especially in the fight against cancer. NINGBO INNO PHARMCHEM CO.,LTD. is a key provider of this essential research chemical.

The compound is characterized by its impressive 1-Acetoxychavicol Acetate anti-tumor activity. This means it has shown a remarkable ability to inhibit or slow down the growth of tumors, a critical feature for developing new cancer drugs. Researchers keen on exploring novel therapeutic strategies will find the buy 1'-Acetoxychavicol Acetate online option from NINGBO INNO PHARMCHEM CO.,LTD. a convenient way to access this valuable compound.

Beyond its anti-tumor effects, 1'-Acetoxychavicol Acetate is also recognized for its role in inducing apoptosis, a process of programmed cell death essential for eliminating damaged or unwanted cells. This makes it a promising candidate for therapies aimed at targeting cancer cells specifically. Understanding the 1-Acetoxychavicol Acetate apoptosis induction mechanisms is paramount for advancing cancer treatment modalities.

For professionals involved in pharmaceutical intermediates for cancer research, the availability of pure and well-characterized compounds like 1'-Acetoxychavicol Acetate is vital. NINGBO INNO PHARMCHEM CO.,LTD. ensures that its products meet the high standards required for such sensitive research. By studying the detailed CAS 52946-22-2 chemical properties, scientists can optimize its use in various experimental designs.

NINGBO INNO PHARMCHEM CO.,LTD. plays a crucial role in supplying the scientific community with the tools needed for discovery. Our dedication to quality and accessibility means researchers can confidently source 1'-Acetoxychavicol Acetate to explore its full therapeutic potential and contribute to the development of next-generation cancer therapies.